170 related articles for article (PubMed ID: 20300435)
1. Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis.
Blaha M; Pit'ha J; Blaha V; Lanska M; Maly J; Filip S; Langrova H
J Biomed Biotechnol; 2010; 2010():419520. PubMed ID: 20300435
[TBL] [Abstract][Full Text] [Related]
2. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
3. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal whole blood immuno-adsorption of passively transferred myasthenia gravis rabbits by cellulose-tryptophan column.
Li XH; Cheng Y; Yang L; Wang SQ; Yu YT
Artif Cells Blood Substit Immobil Biotechnol; 2010 Aug; 38(4):186-91. PubMed ID: 20380507
[TBL] [Abstract][Full Text] [Related]
5. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.
Berta E; Confalonieri P; Simoncini O; Bernardi G; Busnach G; Mantegazza R; Cornelio F; Antozzi C
Int J Artif Organs; 1994 Nov; 17(11):603-8. PubMed ID: 7744521
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption therapy for myasthenia gravis.
Shibuya N; Sato T; Osame M; Takegami T; Doi S; Kawanami S
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):578-81. PubMed ID: 8201327
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
Somnier FE; Langvad E
J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
[TBL] [Abstract][Full Text] [Related]
9. Experience with extracorporeal elimination therapy in myasthenia gravis.
Blaha M; Pitha J; Blaha V; Lanska M; Maly J; Filip S; Brndiar M; Langrova H
Transfus Apher Sci; 2011 Dec; 45(3):251-6. PubMed ID: 22018894
[TBL] [Abstract][Full Text] [Related]
10. Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis.
Takamori M; Ide Y
Transfus Sci; 1996 Sep; 17(3):445-53. PubMed ID: 10163553
[TBL] [Abstract][Full Text] [Related]
11. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients.
Benny WB; Sutton DM; Oger J; Bril V; McAteer MJ; Rock G
Transfusion; 1999 Jul; 39(7):682-7. PubMed ID: 10413274
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.
Ichikawa M; Koh CS; Hata Y; Tohyama M; Tsuno T; Komiyama A
Arch Dis Child; 1993 Aug; 69(2):236-8. PubMed ID: 8215529
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
Haupt WF; Rosenow F; van der Ven C; Birkmann C
Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
[TBL] [Abstract][Full Text] [Related]
15. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide.
Flachenecker P; Taleghani BM; Gold R; Grossmann R; Wiebecke D; Toyka KV
Transfus Sci; 1998 Mar; 19 Suppl():43-6. PubMed ID: 10178693
[TBL] [Abstract][Full Text] [Related]
17. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
18. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
[TBL] [Abstract][Full Text] [Related]
19. Juvenile myasthenia gravis: a twenty-year experience.
Castro D; Derisavifard S; Anderson M; Greene M; Iannaccone S
J Clin Neuromuscul Dis; 2013 Mar; 14(3):95-102. PubMed ID: 23492460
[TBL] [Abstract][Full Text] [Related]
20. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
